4-[4-(4-氯苯氧基)苯基]-4-氧代丁酸 | 57148-29-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-[4-(4-氯苯氧基)苯基]-4-氧代丁酸
• 英文名称: 3-<4-(4-chlorophenoxy)benzoyl>propionic acid
• 英文别名: NCI0061852；3-[4-(4-chlorophenoxy)benzoyl]propionic acid；β-propionsaeure；Benzenebutanoic acid, 4-(4-chlorophenoxy)-gamma-oxo-；4-[4-(4-chlorophenoxy)phenyl]-4-oxobutanoic acid
• CAS: 57148-29-5
• 化学式: C₁₆H₁₃ClO₄
• 分子量: 304.73
• InChiKey: RBSRTJKBLCCGPO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  21
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-[4-(4-氯苯氧基)苯基]-4-氧代丁酸 在 溴 作用下， 以 氯仿 、 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 生成 3-acetylthio-3-<4-(4-chlorophenoxy)benzoyl>propionic acid
  参考文献：
  名称：

  降血脂药的研究。二。3-（4-苯氧基苯甲酰基）-丙酸衍生物。

  摘要：

  合成了3-(4-苯氧基苯甲酰)丙酸，并在正常大鼠中测试其降脂活性。结构-活性关系研究表明，2-乙酰硫代衍生物具有降脂活性。在这些化合物中，2-乙酰硫代-[3-(4-氯苯氧基)苯甲酰]丙酸具有非常强的活性。

  DOI：

  10.1248/cpb.33.2386
• 作为产物：
  描述：

  在 盐酸 、 potassium carbonate 作用下， 以 正己烷 、 N,N-二甲基乙酰胺 为溶剂， 反应 17.0h， 生成 4-[4-(4-氯苯氧基)苯基]-4-氧代丁酸
  参考文献：
  名称：

  Antihypertensive agents: angiotensin converting enzyme inhibitors. 1-[3-(Acylthio)-3-aroylpropionyl]-L-prolines

  摘要：

  A series of 1-[3-(acylthio)-3-aroylpropionyl]-L-proline derivatives was synthesized. A number of these compounds are potent angiotensin converting enzyme (ACE) inhibitors that lowered blood pressure in aorta-coarcted renal hypertensive rats. The most active derivatives are 1-[3(R)-(acetylthio) -3-substituted-benzoyl)-2(S)-methyl-propionyl]-L-prolines with an in vivo activity equivalent to SQ 14,225 (captopril). Structure-activity relationships are discussed. Changes in the configuration of the alpha-methyl group and the S-acetyl group affect the ACE activity. Coupling of 3-(substituted-benzoyl)-2-methylpropionic acids to L-proline via enol lactones is described.

  DOI：

  10.1021/jm00357a013

文献信息

• [4R]-3-(.omega.-Aroylpropionyl)-4-thiazolidinecarboxylic acids and esters
  申请人：American Cyanamid Company

  公开号：US04374249A1

  公开（公告）日：1983-02-15

  This disclosure describes novel [4R]-3-(.omega.-aroylpropionyl)-4-thiazolidinecarboxylic acids and esters and the cationic salts thereof which are useful as hypotensive agents in mammals.

  这份披露描述了新型的[4R]-3-(.omega.-芳酰基丙酰基)-4-噻唑烷甲酸及其酯以及相应的阳离子盐，它们在哺乳动物中作为降压剂是有用的。
• Substituted N-(.omega.-aroylpropionyl) derivatives of .alpha.-amino
  申请人：American Cyanamid Company

  公开号：US04435329A1

  公开（公告）日：1984-03-06

  Novel compounds are described having the formula ##STR1## wherein Z is ##STR2## R.sub.1 is hydrogen or a C.sub.1 -C.sub.4 lower alkyl; R.sub.2 is hydrogen, a C.sub.1 -C.sub.4 lower alkyl, hydroxy-R.sub.8 -, lower alkyl-R.sub.8 -, mercapto-R.sub.8 -, cyclohexyl, cyclopentyl, phenyl, phenyl-R.sub.8 -, indolyl-R.sub.8 -, carboxy-R.sub.8 -, amino-R.sub.8 - or carbamoyl-R.sub.8 -, wherein R.sub.8 - is a divalent C.sub.1 -C.sub.6 straight chain parafinic moiety; R.sub.3 is hydrogen or C.sub.1 -C.sub.4 lower alkyl; R.sub.4 is hydrogen, lower alkanoyl, benzoyl or phenyl-substituted-lower alkanoyl; R.sub.5 is hydrogen or a C.sub.1 -C.sub.4 lower alkyl; R.sub.1, R.sub.2 and R.sub.5 excluding tertiary butyl; ARYL is 1-naphthyl, 2-naphthyl, 4-chloro-1-naphthyl, 4-methoxy-1-naphthyl, 5,6,7,8-tetrahydro-1-naphthyl, 5,6,7,8-tetrahydro-2-naphthyl, 4-biphenylyl, 5-indanyl, 4-indanyl, phenyl, or substituted phenyl moieties having the formula ##STR3## wherein R.sub.6 is fluoro, chloro, bromo, trifluoromethyl, cyano, phenoxy, halophenoxy, phenylthio, halophenylthio, a C.sub.1 -C.sub.4 lower alkyl or a C.sub.1 -C.sub.4 lower alkoxy, and R.sub.7 is chloro, fluoro, bromo, a C.sub.1 -C.sub.4 lower alkyl or a C.sub.1 -C.sub.4 lower alkoxy; and where m is an integer of zero, one or two; including individual optically active isomers; racemic mixtures thereof; non-toxic pharmacologically-acceptable salts of the foregoing; and mixtures of the foregoing. Processes of preparing such compounds are also described. Such compounds are useful in ameliorating hypertension in mammals.

  描述了具有以下公式的新化合物##STR1##其中Z为##STR2##R.sub.1为氢或C.sub.1-C.sub.4较低的烷基; R.sub.2为氢，C.sub.1-C.sub.4较低的烷基，羟基-R.sub.8-，较低的烷基-R.sub.8-，巯基-R.sub.8-，环己基，环戊基，苯基，苯基-R.sub.8-，吲哚基-R.sub.8-，羧基-R.sub.8-，氨基-R.sub.8-或氨基-R.sub.8-，其中R.sub.8-为双价的C.sub.1-C.sub.6直链烷烃基; R.sub.3为氢或C.sub.1-C.sub.4较低的烷基; R.sub.4为氢，较低的烷酰基，苯甲酰基或苯基取代的较低的烷酰基; R.sub.5为氢或C.sub.1-C.sub.4较低的烷基; R.sub.1，R.sub.2和R.sub.5不包括叔丁基; ARYL为1-萘基，2-萘基，4-氯-1-萘基，4-甲氧基-1-萘基，5,6,7,8-四氢-1-萘基，5,6,7,8-四氢-2-萘基，4-联苯基，5-吲哚基，4-吲哚基，苯基，或取代的苯基基团，具有以下公式##STR3##其中R.sub.6为氟，氯，溴，三氟甲基，氰基，苯氧基，卤苯氧基，苯硫基，卤苯硫基，C.sub.1-C.sub.4较低的烷基或C.sub.1-C.sub.4较低的烷氧基，而R.sub.7为氯，氟，溴，C.sub.1-C.sub.4较低的烷基或C.sub.1-C.sub.4较低的烷氧基; m为零，一或二的整数; 包括各个光学活性异构体; 其外消旋混合物; 上述化合物的无毒的药理学上可接受的盐; 和上述混合物。还描述了制备这种化合物的方法。这些化合物在改善哺乳动物的高血压方面是有用的。
• [EN] HISTAMINE H3 RECEPTOR LIGANDS<br/>[FR] LIGANDS DU RÉCEPTEUR H3 DE L'HISTAMINE
  申请人：HIGH POINT PHARMACEUTICALS LLC

  公开号：WO2009126782A1

  公开（公告）日：2009-10-15

  The present invention provides compounds of the formula (I) wherein R1 and R2 and B are as herein described, pharmaceutical compositions comprising these compounds, use of these compounds for the preparation of pharmaceutical compositions and methods of use thereof for the treatment and/or prevention of disorders and diseases wherein modulation of the H3 receptor is beneficial.

  本发明提供了以下式(I)的化合物，其中R1和R2和B如本文所述，包括这些化合物的药物组合物，利用这些化合物制备药物组合物以及利用这些化合物进行治疗和/或预防调节H3受体有益的疾病和疾病的方法。
• Histamine H3 Receptor Ligands
  申请人：Andersen Knud Erik

  公开号：US20110009420A1

  公开（公告）日：2011-01-13

  The present invention provides compounds of the formula wherein R 1 , R 2 and B are as herein described, pharmaceutical compositions comprising these compounds, use of these compounds for the preparation of pharmaceutical compositions and methods of use thereof for the treatment and/or prevention of disorders and diseases wherein modulation of the H 3 receptor is beneficial.

  本发明提供了以下式子的化合物，其中R1、R2和B的定义如下，还提供了包含这些化合物的药物组合物，使用这些化合物制备药物组合物的方法以及使用这些化合物治疗和/或预防调节H3受体有益的疾病和疾病的方法。
• Diarylhydroxy alkanones and alkanones antiallergy agents
  申请人：USV PHARMACEUTICAL CORPORATION

  公开号：EP0184853A2

  公开（公告）日：1986-06-18

  This invention relates to new chemical compounds which possess valuable therapeutic activity particularly as lipoxygenase inhibitors possessing antiflammatory and antiallergic properties. The present new compounds are of the formula wherein, Z and Z, each are alkylene chains containing up to three carbon atoms in the principal chain and a total of up to five carbon atoms and include from 0-1 double bonds; R is H or lower alkyl; R, and R, each are H, lower alkyl, OH, lower alkoxy, benzyloxy, carboxy, alkylenecarboxy or alkylcarbonyl. R, IS H, lower alkyl, aralkyl or lower alkanoyl; and X IS -O(CH2)n -, -CH =CH-, - (CH2)n -, -S(CH2)n- or

  本发明涉及具有重要治疗活性的新化合物，特别是作为具有抗炎和抗过敏特性的脂氧合酶抑制剂。本发明的新化合物的化学式为 其中 Z 和 Z，各自为亚烷基链，在主链中最多含有三个碳原子，总共最多含有五个碳原子，包括 0-1 个双键； R 是 H 或低级烷基； R，和 R，各自是 H、低级烷基、OH、低级烷氧基、苄氧基、羧基、亚烷基羧基或 烷基羰基。 R，IS H、低级烷基、芳基或低级烷酰基；以及 X IS -O(CH2)n-, -CH =CH-, - (CH2)n-, -S(CH2)n- 或